News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
264,515 Results
Type
Article (14104)
Company Profile (282)
Press Release (250129)
Section
Business (79471)
Career Advice (152)
Deals (13221)
Drug Delivery (35)
Drug Development (50403)
Employer Resources (31)
FDA (5703)
Job Trends (5125)
News (144307)
Policy (10025)
Tag
Academia (908)
Alliances (21610)
Alzheimer's disease (796)
Antibody-drug conjugate (ADC) (75)
Approvals (5705)
Artificial intelligence (93)
Bankruptcy (102)
Best Places to Work (4561)
Biotechnology (232)
Breast cancer (130)
Cancer (1112)
Cardiovascular disease (88)
Career advice (132)
CAR-T (92)
Cell therapy (272)
Clinical research (40559)
Collaboration (436)
Compensation (184)
COVID-19 (1028)
C-suite (117)
Cystic fibrosis (74)
Data (1150)
Diabetes (105)
Diagnostics (1278)
Earnings (29212)
Events (47665)
Executive appointments (353)
FDA (6209)
Funding (414)
Gene editing (76)
Gene therapy (199)
GLP-1 (338)
Government (1072)
Healthcare (6571)
Infectious disease (1079)
Inflammatory bowel disease (105)
IPO (7247)
Job creations (859)
Job search strategy (127)
Layoffs (196)
Legal (1383)
Lung cancer (164)
Manufacturing (103)
Medical device (2577)
Medtech (2578)
Mergers & acquisitions (6208)
Metabolic disorders (315)
Neuroscience (1108)
NextGen: Class of 2025 (2013)
Non-profit (853)
Northern California (1339)
Obesity (166)
Opinion (96)
Parkinson's disease (89)
Patents (86)
People (25360)
Phase I (14316)
Phase II (18874)
Phase III (11922)
Pipeline (504)
Postmarket research (852)
Preclinical (5997)
Radiopharmaceuticals (209)
Rare diseases (248)
Real estate (1415)
Regulatory (8439)
Research institute (934)
Series A (82)
Southern California (1188)
Startups (1969)
United States (10548)
Vaccines (189)
Weight loss (96)
Date
Last 7 days (339)
Last 30 days (1445)
Last 365 days (20385)
2025 (2645)
2024 (20570)
2023 (22420)
2022 (26825)
2021 (27809)
2020 (23358)
2019 (16223)
2018 (11738)
2017 (13746)
2016 (11843)
2015 (14352)
2014 (10393)
2013 (7485)
2012 (7532)
2011 (7616)
2010 (7430)
Location
Africa (148)
Asia (17096)
Australia (2893)
California (3047)
Canada (965)
China (269)
Colorado (115)
Connecticut (130)
Delaware (72)
Europe (36782)
Florida (348)
Georgia (91)
Illinois (192)
Indiana (73)
Maryland (396)
Massachusetts (2385)
Minnesota (119)
New Jersey (762)
New York (835)
North Carolina (475)
Northern California (1339)
Ohio (98)
Pennsylvania (577)
South America (207)
Southern California (1188)
Texas (337)
Washington State (307)
264,515 Results for "immunomic therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immunome Announces Proposed Public Offering of Common Stock
January 30, 2025
·
4 min read
Press Releases
Immunome Announces Pricing of Upsized Public Offering of Common Stock
January 30, 2025
·
4 min read
Press Releases
Hummingbird Bioscience Licenses Novel Antibodies to Immunome
January 7, 2025
·
2 min read
Business
Immunome Appoints Phil Tsai as Chief Technical Officer
Immunome, Inc. today announced the appointment of Phil Tsai, PhD, as Chief Technical Officer.
June 27, 2024
·
5 min read
Press Releases
Immunome Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
February 2, 2025
·
4 min read
Press Releases
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 6, 2025
February 7, 2025
·
2 min read
Press Releases
Immunome Provides Pipeline Update in Advance of Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
January 13, 2025
·
3 min read
Business
Immunome Announces Completion of Purchase of Assets from Atreca
Immunome, Inc. today announced the completion of its purchase of antibodies and related assets from Atreca, Inc.
May 20, 2024
·
4 min read
Press Releases
Immunome to Present at the Piper Sandler 36th Annual Healthcare Conference
November 27, 2024
·
2 min read
Business
Immunome Announces Promotion of Max Rosett to Chief Financial Officer
Immunome, Inc. today announced the promotion of Max Rosett to Chief Financial Officer, effective May 9.
May 17, 2024
·
5 min read
1 of 26,452
Next
